These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20506555)

  • 21. Symptomatic carotid stenosis: endarterectomy, stenting, or best medical management?
    McKinsey JF
    Semin Vasc Surg; 2008 Jun; 21(2):108-14. PubMed ID: 18565418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carotid angioplasty in asymptomatic patients undergoing CABG surgery.
    Polydorou AD; Megaloikonomos P; Moutiris JA; Polydorou V; Antypa E; Testembasi E; Tziakouri CH; Palatianos G; Nikas D; Bolos K; Polydorou A
    Int Angiol; 2010 Jun; 29(3):239-43. PubMed ID: 20502410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial.
    Hopkins LN; Myla S; Grube E; Wehman JC; Levy EI; Bersin RM; Joye JD; Allocco DJ; Kelley L; Baim DS
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):950-60. PubMed ID: 18412236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carotid stenting trials: what have they taught us?
    Chung C; Shah TR; Han D; Marin ML; Faries PL
    Perspect Vasc Surg Endovasc Ther; 2010 Jun; 22(2):93-103. PubMed ID: 20858611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endovascular treatment of extracranial carotid artery stenosis: update on carotid angioplasty and stenting.
    Cullen SP; Higashida RT
    Neuroimaging Clin N Am; 2005 May; 15(2):383-95, xi. PubMed ID: 16198947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
    Calkins H; Kuck KH; Cappato R; Brugada J; Camm AJ; Chen SA; Crijns HJ; Damiano RJ; Davies DW; DiMarco J; Edgerton J; Ellenbogen K; Ezekowitz MD; Haines DE; Haissaguerre M; Hindricks G; Iesaka Y; Jackman W; Jalife J; Jais P; Kalman J; Keane D; Kim YH; Kirchhof P; Klein G; Kottkamp H; Kumagai K; Lindsay BD; Mansour M; Marchlinski FE; McCarthy PM; Mont JL; Morady F; Nademanee K; Nakagawa H; Natale A; Nattel S; Packer DL; Pappone C; Prystowsky E; Raviele A; Reddy V; Ruskin JN; Shemin RJ; Tsao HM; Wilber D
    Europace; 2012 Apr; 14(4):528-606. PubMed ID: 22389422
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials in neonatal sepsis.
    Oeser C; Lutsar I; Metsvaht T; Turner MA; Heath PT; Sharland M
    J Antimicrob Chemother; 2013 Dec; 68(12):2733-45. PubMed ID: 23904558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evidence for medicine versus surgery for carotid stenosis.
    Ederle J; Brown MM
    Eur J Radiol; 2006 Oct; 60(1):3-7. PubMed ID: 16920313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.
    Savitz SI; Benatar M; Saver JL; Fisher M
    Cerebrovasc Dis; 2008; 26(2):156-62. PubMed ID: 18560219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. You get what you measure: evaluating endpoints in MS clinical trials.
    Marrie RA
    Neurology; 2008 Aug; 71(9):620-1. PubMed ID: 18685132
    [No Abstract]   [Full Text] [Related]  

  • 31. Endarterectomy for preventing stroke in symptomatic and asymptomatic carotid stenosis. Review of clinical trials and recommendations for surgical therapy.
    Levinson MM; Rodriguez DI
    Heart Surg Forum; 1999; 2(2):147-68. PubMed ID: 11276473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary stroke prevention in the era of carotid stenting: update on recent trials.
    Hassoun HT; Malas MB; Freischlag JA
    Arch Surg; 2010 Oct; 145(10):928-35. PubMed ID: 20956760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What we learned about trials from the European Carotid Stent Trials.
    Zeebregts CJ; Cheshire NJ; Bosiers M; Cao P; Verhoeven EL
    Ann Vasc Surg; 2008 Jan; 22(1):159-61. PubMed ID: 18083342
    [No Abstract]   [Full Text] [Related]  

  • 34. Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardization.
    Dahl OE
    Thromb Res; 2012 Oct; 130 Suppl 1():S32. PubMed ID: 23026656
    [No Abstract]   [Full Text] [Related]  

  • 35. Surgical treatment of great vessel occlusive disease.
    Tracci MC; Cherry KJ
    Surg Clin North Am; 2009 Aug; 89(4):821-36, viii. PubMed ID: 19782839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
    Hicks KA; Tcheng JE; Bozkurt B; Chaitman BR; Cutlip DE; Farb A; Fonarow GC; Jacobs JP; Jaff MR; Lichtman JH; Limacher MC; Mahaffey KW; Mehran R; Nissen SE; Smith EE; Targum SL; ;
    Circulation; 2015 Jul; 132(4):302-61. PubMed ID: 25547519
    [No Abstract]   [Full Text] [Related]  

  • 37. What we want versus what we can get: a closer look at failure time endpoints for cardiovascular studies.
    Song R; Cook TD; Kosorok MR
    J Biopharm Stat; 2008; 18(2):370-81. PubMed ID: 18327727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    Hicks KA; Mahaffey KW; Mehran R; Nissen SE; Wiviott SD; Dunn B; Solomon SD; Marler JR; Teerlink JR; Farb A; Morrow DA; Targum SL; Sila CA; Hai MTT; Jaff MR; Joffe HV; Cutlip DE; Desai AS; Lewis EF; Gibson CM; Landray MJ; Lincoff AM; White CJ; Brooks SS; Rosenfield K; Domanski MJ; Lansky AJ; McMurray JJV; Tcheng JE; Steinhubl SR; Burton P; Mauri L; O'Connor CM; Pfeffer MA; Hung HMJ; Stockbridge NL; Chaitman BR; Temple RJ;
    Circulation; 2018 Feb; 137(9):961-972. PubMed ID: 29483172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comments on guidelines for therapeutic studies in Fontaine's stage II-IV peripheral arterial occlusive disease].
    Heidrich H; Trampisch HJ; Roehmel J
    Vasa; 1996; 25(1):73-5. PubMed ID: 8851269
    [No Abstract]   [Full Text] [Related]  

  • 40. Missing data in confirmatory clinical trials.
    Flyer P; Hirman J
    J Biopharm Stat; 2009 Nov; 19(6):969-79. PubMed ID: 20183459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.